series-a
Stage
2021
Founded
2
Investors
About
Verinnogen develops handheld 3D surface profiling technology to measure subcutaneous tumors in preclinical cancer research, improving accuracy and repeatability to accelerate drug development.
Explore Verinnogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.